This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Novavax Inc. (NVAX) plunged 10.71% to $16.92 Tuesday, on what proved to be an all-around positive trading session for the stock market, with the NASDAQ Composite Index rising 1.36% to 11,174.41 and the Dow Jones Industrial Average rising 1.18% to 34,098.10. This was the stock's fifth consecutive day of losses. Novavax Inc. closed $219.58 below its 52-week high ($236.50), which the company reached on December 20th.
The stock underperformed when compared to some of its competitors Tuesday, as Replimune Group Inc. (REPL) rose 5.14% to $19.84, VBI Vaccines Inc. (VBIV) fell 0.69% to $0.59, and AnaptysBio Inc. (ANAB) rose 3.33% to $27.94. Trading volume (6.4 M) eclipsed its 50-day average volume of 5.2 M.
Data source: Dow Jones Market Data, FactSet. Data compiled November 22, 2022.
(END) Dow Jones Newswires
November 22, 2022 17:13 ET (22:13 GMT)
Copyright (c) 2022 Dow Jones & Company, Inc.